Ticagrelor in Severe Community Acquired Pneumonia

Summary

The purpose of this study is to determine if the drug ticagrelor will be an effective treatment for patients with severe community acquired pneumonia. The primary objective is to reduce all-cause mortality in the ticagrelor group compared to the placebo group.

Timeline

Start

2014-08

Primary completion

2015-12

Completion

2015-12

Drugs

Indications